SCHEMBL4436670

SCHEMBL4436670

O=c1[nH]ccc2n[c]ncc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.37
KDM4A O75164 1/20 0.36
KDM4B O94953 1/20 0.36
KDM5C P41229 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
KDM3A Q9Y4C1 1/20 0.36
ALDH1A1 P00352 4/20 0.34
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
RAB9A P51151 1/20 0.34
BLM P54132 1/20 0.34
PARP15 Q460N3 1/20 0.34
HSD17B10 Q99714 1/20 0.34
RECQL P46063 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35179 0.72
SCHEMBL29624620 0.72 KDM4A (0.41) PARP1KDM4AKDM4BKDM5CKDM4C
SCHEMBL22207528 0.72 PARP1 (0.38) PARP1KDM4AKDM4BKDM5CKDM4C
SCHEMBL1940496 0.72 KDM4A (0.41) PARP1KDM4AKDM4BKDM5CKDM4C
SCHEMBL7744423 0.71 AHR (0.35)
Hydrochloric Acid SCHEMBL30705348 0.70 KDM4A (0.40) PARP1KDM4AKDM4BKDM5CKDM4C
Hydrochloric Acid SCHEMBL30705349 0.70 KDM4A (0.40) PARP1KDM4AKDM4BKDM5CKDM4C
SCHEMBL30656412 0.66 PARP1 (0.41) PARP1KDM4AKDM4BKDM5CKDM4C
SCHEMBL29722257 0.66 PARP1 (0.40) PARP1KDM4AKDM4BKDM5CKDM4C
SCHEMBL28349050 0.66 KDM4E (0.43) PARP1KDM4AKDM4BKDM5CKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012485-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2013-01-10 US disclosed
EP-2124913-A1 1-AMINOMETHYL- L- PHENYL- CYCLOHEXANE DERIVATIVES AS DDP-IV INHIBITORS Novartis AG (CH) 2009-12-02 EP disclosed
WO-2008077597-A1 1-AMINOMETHYL- L- PHENYL- CYCLOHEXANE DERIVATIVES AS DDP-IV INHIBITORS NOVARTIS AG (CH) 2008-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012485-A1 ORGANIC COMPOUNDS DPP4, DPP3, DPP7 PARP1 2601/4885KDM4A 278/4885KDM4B 360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.